Detalhe da pesquisa
1.
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination.
Immunity
; 55(9): 1732-1746.e5, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961317
2.
Incidence of cardiovascular and bleeding events and reasons for discontinuation in patients with chronic lymphocytic leukemia treated with ibrutinib-A retrospective analysis on consecutive patients from a well-defined region.
Eur J Haematol
; 111(5): 748-756, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37565648
3.
Idelalisib (PI3Kδ inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients.
Eur J Haematol
; 111(5): 715-721, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37501508
4.
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.
Mol Med
; 28(1): 20, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135470
5.
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study.
Haematologica
; 106(1): 87-97, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31974198
6.
Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patients.
Br J Haematol
; 191(3): 426-432, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32779190
7.
Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination.
Blood
; 140(22): 2403-2407, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150168
8.
First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013.
Haematologica
; 104(4): 797-804, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30467205
9.
Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia.
Haematologica
; 109(2): 646-651, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646668
10.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297826
11.
Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients.
Eur J Haematol
; 101(1): 68-77, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29569742
12.
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.
Cancer Immunol Immunother
; 66(1): 91-102, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27815572
13.
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.
Haematologica
; 102(3): 562-572, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27927767
14.
T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial.
Haematologica
; 107(4): 1000-1003, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045694
15.
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia.
Ann Hematol
; 96(10): 1681-1691, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28762081
16.
Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia.
Tumour Biol
; 37(9): 11947-11957, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27086035
17.
Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group.
Haematologica
; 101(12): 1573-1580, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27198718
18.
Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort.
Haematologica
; 104(5): e208-e210, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514799
19.
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant.
Cell Host Microbe
; 32(2): 156-161.e3, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38211584
20.
T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile.
Cancer Immunol Immunother
; 62(1): 51-63, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22736254